Titan Biotech Ltd announced a 1:4 bonus share issue, granting one bonus share for every four shares held, with the record date set for October 23, 2026. The company’s shares have surged over 550% in the past five years, marking it as a multibagger stock. Titan Biotech will trade ex-bonus on the record date, and investors have until October 22 to purchase shares to qualify for the bonus issue, according to livemint.com.
The company received in-principal approval from BSE Limited on October 7, 2026, under SEBI regulations to issue the bonus shares. Titan Biotech also paid a final dividend of ₹0.50 per share on September 22, 2026, continuing its history as a dividend-paying stock. The bonus share announcement was made through an official exchange filing, signaling confidence in the company’s growth prospects and shareholder returns.
Titan Biotech’s bonus share issuance follows a period of significant share price appreciation, reflecting strong investor demand and company performance. The stock’s 550% return over five years places it among notable multibagger stocks in the Indian market. This move aligns with similar corporate actions by firms rewarding shareholders amid sustained growth, enhancing liquidity and potentially broadening the shareholder base.
The record date for the bonus shares is October 23, 2026, with the shares trading ex-bonus on the same day. Investors aiming to benefit from the 1:4 bonus ratio must acquire shares by October 22. Titan Biotech’s continued dividend payments and recent bonus share issue highlight its commitment to shareholder value, as documented by livemint.com.